Report
Zhen Zhou Toh
EUR 116.30 For Business Accounts Only

Aequitas 2022 Asia IPO Pipeline

In this note, we will take a look at the Asia Pacific IPO pipeline for 2022. This list has been compiled on a best effort basis from tracking the company filings and through various other sources.

For readers who are not familiar with our coverage, we aim to cover all IPOs and placements with a minimum deal size of US$100m across Asia-Pacific (ex A-shares), including China ADRs. Hence, our pipeline will only include companies that fit these criteria.

The deals you see in this note are only a part of our full IPO pipeline tracker. Feel free to drop us a message for additional information (bookrunners and coverage) on these IPOs.
Underlying
LG Chem Ltd.

LG Chem is engaged in the business of chemicals and polymers, industrial materials and information and electronic materials. Co. provides polyvinyl chloride products, plasticizers, polyethylene compounds, acrylic acids, engineering plastics, elastomers and conductive resins. Co. also manufactures lithium-ion batteries, printed circuit materials, toner, photosensitive materials, and organic light-emitting diode (OLED) materials.

Provider
Aequitas Research
Aequitas Research

Aequitas Research is a leading ECM research firm with a focus on IPOs and placements/follow-on offerings across the Asia Pacific with deal size of over USD100m. 

Since 2015, we have covered 400+ IPOs and 450+ placements with a hit rate of 73% and 65%, respectively. We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic analysis.
 
Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis. We also provide a more quant driven analysis on placement/follow-on offerings.
 
Markets that we cover include:
Hong Kong,
China ADRs,
India,
Japan,
Australia, and
ASEAN.

Analysts
Zhen Zhou Toh

Other Reports on these Companies
Other Reports from Aequitas Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch